Research GradeMod GRF 1-29 · 1-2-Day Delivery to Cheltenham
A GHRH analogue investigated for growth hormone pathway modulation. Studies indicate CJC-1295 may stimulate pulsatile GH release via pituitary GHRH receptors with an extended half-life profile.
Research indicates CJC-1295 binds to GHRH receptors on the pituitary gland, stimulating pulsatile GH release. The modification extends half-life compared to native GHRH, providing sustained GH elevation in study models.
Peptides Pharma delivers CJC-1295 research vials directly to Cheltenham with 1-2-day tracked delivery. Order online at peptidespharma.com and receive your research-grade lyophilized vial at your door.
Peptides Pharma CJC-1295 is priced at €55 per vial, which contains a 30-day supply of 2mg in a pre-mixed, ready-to-use vial system. Free UK delivery on orders over €175.
Yes, CJC-1295 is legal to purchase for research purposes in Cheltenham and across the UK. Peptides Pharma products are sold strictly for research use only.
Peptides Pharma CJC-1295 exceeds 99% purity, verified by independent HPLC analysis. Each batch comes with a Certificate of Analysis from a third-party laboratory.
Mod GRF 1-29 (without DAC) has a shorter half-life (~30 minutes) producing acute GH pulses. The DAC modification extends the half-life to 6-8 days for sustained elevation. Both are used in GH research with different dosing protocols.
Yes, they work through complementary pathways. CJC-1295 amplifies GH release via GHRH receptors while Ipamorelin stimulates via the ghrelin receptor. Many researchers study this combination for synergistic GH research.
1-2-day tracked delivery. Pre-mixed & ready to use. >99% purity guaranteed.
ORDER CJC-1295 — €55
